Benzinga · May 23, 2023
Gainers
Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales.
SeqLL Inc. (NASDAQ: SQL) shares surged 34.3% to $0.5377 in pre-market trading after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss.
HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 21.1% to $1.55 in pre-market trading following better-than-expected first-quarter results.
Bone Biologics Corporation (NASDAQ: BBLG) shares gained 18.8% to $0.1960 in pre-market trading after gaining over 10% on Monday.
Movella Holdings Inc. (NASDAQ: MVLA) rose 18.5% to $2.28 in pre-market trading after jumping around 18% on Monday.
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares rose 14.4% to $1.99 in pre-market trading. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants.
Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) shares gained 14.1% to $0.1275 in pre-market trading after the company reported the sale of preferred ...
Benzinga · Dec 14, 2022
U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision.
The Dow traded down 0.99% to 33,771.65 while the NASDAQ fell 1.52% to 11,085.67. The S&P 500 also fell, dropping, 1.12% to 3,974.57.
Also check this: Bitcoin Tops $18,000; GMX, Dogecoin Among Top Losers
Leading and Lagging Sectors
Health care shares rose by 0.2% on Wednesday. Meanwhile, top gainers in the sector included Avidity Biosciences, Inc. (NASDAQ: RNA), up 62%, and Icosavax, Inc. (NASDAQ: ICVX), up 61%.
In trading on Wednesday, materials shares fell by 1%.
Top Headline
The Federal Reserve raised its target fed funds rate by 0.5% on Wednesday to a new range of between 4.25% and 4.5%.
The Fed said it will continue with its previously announced plan to let Treasury securities and agency debt and agency mortgage-backed securities roll off its balance sheet on a monthly basis.
Equities Trading UP
Avidity Biosciences, Inc. (NASDAQ: RNA) shares shot up 59% to $17.47 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle.
Shares of Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) got a boost, shooting 92% to $0.4828 after the company entered into a definitive merger agreement with GRI Bio.
Immix Biopharma, Inc. ...
Benzinga · Dec 14, 2022
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 140% to $0.6041 after the company entered into a definitive merger agreement with GRI Bio.
Immix Biopharma, Inc. (NASDAQ: IMMX) jumped 46% to $2.1695 after the company announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 with 85% ORR and 71% CR/sCR at the therapeutic dose from the first 20 patients in an ongoing phase 1b relapsed/refractory multiple myeloma ongoing clinical trial.
Senti Biosciences, Inc. (NASDAQ: SNTI) rose 45% to $2.09 after dipping more than 21% on Tuesday.
Avidity Biosciences, Inc. (NASDAQ: RNA) shares climbed 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle.
BIMI International Medical, Inc. (NASDAQ: BIMI) gained 28.1% to $2.6649. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd.
Wave Life Sciences Ltd. (NASDAQ: WVE) gained 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7.
Kymera Therapeutics, Inc. (NASDAQ: KYMR) shares gained 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials.
Aspen Group, Inc. (NASDAQ: ASPU) gained 17.4% to $0.41 after reporting strong quarterly sales.
REV Group, Inc. (NYSE: REVG) jumped 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth ...
Benzinga · Nov 21, 2022
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
Nexalin Technology, Inc. (NASDAQ: NXL) jumped 48% to $2.6650.
SeaStar Medical Holding Corporation (NASDAQ: ICU) shares climbed 47.5% to $5.80.
Sotera Health Company (NASDAQ: SHC) rose 40.4% to $8.45. Barclays, last week, downgraded Sotera Health from Equal-Weight to Underweight and lowered the price target from $7 to $6.
NWTN Inc. (NASDAQ: NWTN) gained 40.3% to $7.13.
Kaspien Holdings Inc. (NASDAQ: KSPN) surged 28.7% to $1.12.
Meta Materials Inc. (NASDAQ: MMAT) shares jumped 25.9% to $2.09 after dropping around 7% on Friday.
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) gained 25% to $1.0375. NeuroOne, last month, received FDA 510(k) clearance to market its Evo sEEG System for less than 30 day use.
GrafTech International Ltd. (NYSE: EAF) gained 22.5% to $5.17 after the company said it could resume operations at its Monterrey, Mexico facility.
Freight Technologies, Inc. (NASDAQ: FRGT) surged 22% to $0.3737 after the company reported Q3 earnings results.
Gelesis Holdings, Inc. (NYSE: GLS) rose 21.1% to $0.4725.
Companhia Paranaense de Energia – COPEL (NYSE: ELP) gained 20.7% to $7.93.
Conformis, Inc. (NASDAQ: CFMS) jumped 19.7% to $2.43. Conformis recently reported the full commercial launch of its new Imprint™ knee system.
GoHealth, Inc. (NASDAQ: GOCO) surged 18.6% to $8.33.
Rigetti Computing, Inc. (NASDAQ: RGTI) gained 13.7% to $1.41.
Cosmos Holdings Inc. (NASDAQ: COSM) rose 12.3% ...
